Meningococcal Vaccines Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Meningococcal Vaccines Market to 2027 - Global Analysis and Forecasts by Type (Quadrivalent Vaccines, Bivalent Vaccines, Serogroup A, Serogroup B, Serogroup X); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Geography

Report Code: TIPRE00004064 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Meningococcal vaccines are used in the treatment of meningitis, septicemia, meningococcemia and pneumonia. Meningitis is the inflammation of the membranes that cover the brain and spinal cord. This type of inflammation is caused by infection of bacteria, viruses and by drugs. Earlier there were no precautionary measures available to avoid meningitis. Antibiotics along with nutrient supplements were used to treat this disease after infection was confirmed.

MARKET DYNAMICS
The meningococcal vaccines market is expected to grow during the forecast period due to presence of various government awareness programs, rising government interventions in refining healthcare infrastructure and incorporation of security guidelines pertaining to meningococcal vaccines. However, stringent regulatory scenario and expiry of key drugs are likely to hamper the growth of the market in the forecast period.

MARKET SCOPE
The "Global Meningococcal Vaccines Market Analysis to 2027" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of enteral feeding formulas market with detailed market segmentation by type, distribution channel and geography. The global meningococcal vaccines market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading enteral feeding formulas market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global meningococcal vaccines market is segmented on the basis of type and distribution channel. Based on type the market is classified as quadrivalent vaccines, bivalent vaccines, serogroup A, serogroup B and serogroup X. On the basis of distribution channel the market is classified as hospital pharmacies, retail pharmacies and online pharmacies.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global meningococcal vaccines market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The meningococcal vaccines market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting meningococcal vaccines market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the meningococcal vaccines market in these regions.

MARKET PLAYERS
The reports cover key developments in the meningococcal vaccines market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from meningococcal vaccines market are anticipated to lucrative growth opportunities in the future with the rising demand for meningococcal vaccines market in the global market. Below mentioned is the list of few companies engaged in the meningococcal vaccines market.

The report also includes the profiles of key meningococcal vaccines market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Pfizer Inc.
  • Baxter
  • Novartis AG
  • Sanofi
  • JN-International Medical Corporation (Verdict Media Limited)
  • BIO-MED
  • Serum Institute of India Pvt. Ltd.
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Hualan Biological Engineering Inc.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Meningococcal Vaccines Market - By Type
1.3.2 Meningococcal Vaccines Market - By Distribution Channel
1.3.3 Meningococcal Vaccines Market - By Region
1.3.3.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. MENINGOCOCCAL VACCINES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. MENINGOCOCCAL VACCINES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. MENINGOCOCCAL VACCINES MARKET - GLOBAL MARKET ANALYSIS
6.1. MENINGOCOCCAL VACCINES - GLOBAL MARKET OVERVIEW
6.2. MENINGOCOCCAL VACCINES - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. MENINGOCOCCAL VACCINES MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. QUADRIVALENT VACCINES
7.3.1. Overview
7.3.2. Quadrivalent Vaccines Market Forecast and Analysis
7.4. BIVALENT VACCINES
7.4.1. Overview
7.4.2. Bivalent Vaccines Market Forecast and Analysis
7.5. SEROGROUP A
7.5.1. Overview
7.5.2. Serogroup A Market Forecast and Analysis
7.6. SEROGROUP B
7.6.1. Overview
7.6.2. Serogroup B Market Forecast and Analysis
7.7. SEROGROUP X
7.7.1. Overview
7.7.2. Serogroup X Market Forecast and Analysis
8. MENINGOCOCCAL VACCINES MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL PHARMACIES
8.3.1. Overview
8.3.2. Hospital Pharmacies Market Forecast and Analysis
8.4. RETAIL PHARMACIES
8.4.1. Overview
8.4.2. Retail Pharmacies Market Forecast and Analysis
8.5. ONLINE PHARMACIES
8.5.1. Overview
8.5.2. Online Pharmacies Market Forecast and Analysis
9. MENINGOCOCCAL VACCINES MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Meningococcal Vaccines Market Overview
9.1.2 North America Meningococcal Vaccines Market Forecasts and Analysis
9.1.3 North America Meningococcal Vaccines Market Forecasts and Analysis - By Type
9.1.4 North America Meningococcal Vaccines Market Forecasts and Analysis - By Distribution Channel
9.1.5 North America Meningococcal Vaccines Market Forecasts and Analysis - By Countries
9.1.5.1 United States Meningococcal Vaccines Market
9.1.5.1.1 United States Meningococcal Vaccines Market by Type
9.1.5.1.2 United States Meningococcal Vaccines Market by Distribution Channel
9.1.5.2 Canada Meningococcal Vaccines Market
9.1.5.2.1 Canada Meningococcal Vaccines Market by Type
9.1.5.2.2 Canada Meningococcal Vaccines Market by Distribution Channel
9.1.5.3 Mexico Meningococcal Vaccines Market
9.1.5.3.1 Mexico Meningococcal Vaccines Market by Type
9.1.5.3.2 Mexico Meningococcal Vaccines Market by Distribution Channel
9.2. EUROPE
9.2.1 Europe Meningococcal Vaccines Market Overview
9.2.2 Europe Meningococcal Vaccines Market Forecasts and Analysis
9.2.3 Europe Meningococcal Vaccines Market Forecasts and Analysis - By Type
9.2.4 Europe Meningococcal Vaccines Market Forecasts and Analysis - By Distribution Channel
9.2.5 Europe Meningococcal Vaccines Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Meningococcal Vaccines Market
9.2.5.1.1 Germany Meningococcal Vaccines Market by Type
9.2.5.1.2 Germany Meningococcal Vaccines Market by Distribution Channel
9.2.5.2 France Meningococcal Vaccines Market
9.2.5.2.1 France Meningococcal Vaccines Market by Type
9.2.5.2.2 France Meningococcal Vaccines Market by Distribution Channel
9.2.5.3 Italy Meningococcal Vaccines Market
9.2.5.3.1 Italy Meningococcal Vaccines Market by Type
9.2.5.3.2 Italy Meningococcal Vaccines Market by Distribution Channel
9.2.5.4 Spain Meningococcal Vaccines Market
9.2.5.4.1 Spain Meningococcal Vaccines Market by Type
9.2.5.4.2 Spain Meningococcal Vaccines Market by Distribution Channel
9.2.5.5 United Kingdom Meningococcal Vaccines Market
9.2.5.5.1 United Kingdom Meningococcal Vaccines Market by Type
9.2.5.5.2 United Kingdom Meningococcal Vaccines Market by Distribution Channel
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Meningococcal Vaccines Market Overview
9.3.2 Asia-Pacific Meningococcal Vaccines Market Forecasts and Analysis
9.3.3 Asia-Pacific Meningococcal Vaccines Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Meningococcal Vaccines Market Forecasts and Analysis - By Distribution Channel
9.3.5 Asia-Pacific Meningococcal Vaccines Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Meningococcal Vaccines Market
9.3.5.1.1 Australia Meningococcal Vaccines Market by Type
9.3.5.1.2 Australia Meningococcal Vaccines Market by Distribution Channel
9.3.5.2 China Meningococcal Vaccines Market
9.3.5.2.1 China Meningococcal Vaccines Market by Type
9.3.5.2.2 China Meningococcal Vaccines Market by Distribution Channel
9.3.5.3 India Meningococcal Vaccines Market
9.3.5.3.1 India Meningococcal Vaccines Market by Type
9.3.5.3.2 India Meningococcal Vaccines Market by Distribution Channel
9.3.5.4 Japan Meningococcal Vaccines Market
9.3.5.4.1 Japan Meningococcal Vaccines Market by Type
9.3.5.4.2 Japan Meningococcal Vaccines Market by Distribution Channel
9.3.5.5 South Korea Meningococcal Vaccines Market
9.3.5.5.1 South Korea Meningococcal Vaccines Market by Type
9.3.5.5.2 South Korea Meningococcal Vaccines Market by Distribution Channel
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Meningococcal Vaccines Market Overview
9.4.2 Middle East and Africa Meningococcal Vaccines Market Forecasts and Analysis
9.4.3 Middle East and Africa Meningococcal Vaccines Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Meningococcal Vaccines Market Forecasts and Analysis - By Distribution Channel
9.4.5 Middle East and Africa Meningococcal Vaccines Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Meningococcal Vaccines Market
9.4.5.1.1 South Africa Meningococcal Vaccines Market by Type
9.4.5.1.2 South Africa Meningococcal Vaccines Market by Distribution Channel
9.4.5.2 Saudi Arabia Meningococcal Vaccines Market
9.4.5.2.1 Saudi Arabia Meningococcal Vaccines Market by Type
9.4.5.2.2 Saudi Arabia Meningococcal Vaccines Market by Distribution Channel
9.4.5.3 U.A.E Meningococcal Vaccines Market
9.4.5.3.1 U.A.E Meningococcal Vaccines Market by Type
9.4.5.3.2 U.A.E Meningococcal Vaccines Market by Distribution Channel
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Meningococcal Vaccines Market Overview
9.5.2 South and Central America Meningococcal Vaccines Market Forecasts and Analysis
9.5.3 South and Central America Meningococcal Vaccines Market Forecasts and Analysis - By Type
9.5.4 South and Central America Meningococcal Vaccines Market Forecasts and Analysis - By Distribution Channel
9.5.5 South and Central America Meningococcal Vaccines Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Meningococcal Vaccines Market
9.5.5.1.1 Brazil Meningococcal Vaccines Market by Type
9.5.5.1.2 Brazil Meningococcal Vaccines Market by Distribution Channel
9.5.5.2 Argentina Meningococcal Vaccines Market
9.5.5.2.1 Argentina Meningococcal Vaccines Market by Type
9.5.5.2.2 Argentina Meningococcal Vaccines Market by Distribution Channel
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. MENINGOCOCCAL VACCINES MARKET, KEY COMPANY PROFILES
11.1. PFIZER INC.
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. BAXTER
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. NOVARTIS AG
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. SANOFI
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. JN-INTERNATIONAL MEDICAL CORPORATION (VERDICT MEDIA LIMITED)
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. BIO-MED
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. SERUM INSTITUTE OF INDIA PVT. LTD.
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. GLAXOSMITHKLINE PLC
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. MERCK & CO., INC.
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. HUALAN BIOLOGICAL ENGINEERING INC.
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Pfizer Inc.
2. Baxter
3. Novartis AG
4. Sanofi
5. JN-International Medical Corporation (Verdict Media Limited)
6. BIO-MED
7. Serum Institute of India Pvt. Ltd.
8. GlaxoSmithKline plc
9. Merck & Co., Inc.
10. Hualan Biological Engineering Inc.